| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.14B | -8.4% | +10.4% |
| Cost of Revenue | $530.0M | +0.4% | +7.7% |
| Gross Profit | $607.0M | -14.9% | +12.8% |
| R&D Expense | $89.0M | -3.3% | +2.3% |
| SG&A Expense | $351.0M | -12.3% | +8.7% |
| Pre-tax Income | -$50.0M | -300.0% | -108.9% |
| Income Tax | -$16.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $505.0M | -6.3% | +3.1% |
| Accounts Receivable | $894.0M | -9.6% | +6.4% |
| Inventory | $1.71B | +2.3% | +4.7% |
| Current Assets | $3.49B | -3.3% | +3.8% |
| Total Assets | $13.55B | -1.4% | +2.0% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $452.0M | — | — |
| Capital Expenditures | $214.0M | — | — |
| Investing Cash Flow | -$215.0M | — | — |
| Financing Cash Flow | -$257.0M | — | — |
| Free Cash Flow | $238.0M | — | — |
| -214.3% |
| -108.2% |
| Net Income | -$34.0M | -409.1% | -109.3% |
| EPS (Basic) | -$0.07 | -450.0% | -109.5% |
| EPS (Diluted) | -$0.07 | -450.0% | -109.6% |
| $1.46B |
| +4.5% |
| +10.1% |
| Long-term Debt | $3.77B | -4.7% | -13.5% |
| Total Liabilities | $6.80B | -2.4% | +0.6% |
| Stockholders' Equity | $6.75B | -0.4% | +3.5% |